Pharmagen ApS: Financial statements 2025
CVR: 36687193
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.
- Gross Profit
- DKK -15,933
- Profit/Loss
- DKK 36,023
- Equity
- DKK -275,141
- Total Assets
- DKK 972,665
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -16 t. | 36 t. | -275 t. | 0 |
| 2024 | - | -14 t. | -19 t. | -311 t. | 0 |
| 2023 | - | -10 t. | 15 t. | -292 t. | 0 |
| 2022 | - | 8 t. | -242 t. | -307 t. | - |
| 2021 | - | 337 t. | 383 t. | -65 t. | - |
Official annual report
How creditworthy is Pharmagen ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.